ACCEPT SIMS AI™

AI-enabled screening intelligence and navigation

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,867
Diagnostic referrals
1,101
Outstanding pathways
376

Screening pathway

  1. Screening5,867Encounters
  2. Positive finding2,099Documented findings
  3. Referral1,101Diagnostic referrals
  4. Follow-up1,284Diagnostic visits
  5. Outcome725Resolved pathways

Stage totals use different units. Pending pathways: 285. Insufficient observation: 91.

Participant insight

Expanded synthetic participant 1908 · EXP-1908Synthetic · Site D

Full participant history through 2028-06-04, across modalities and pathways.

  1. · Screening · HPV DNA · Initial · Programme entry
  2. · Screening result · HPV DNA · HPV detected · Adequate
  3. · Repeat plan · HPV DNA · Prior HPV positive · Scheduled for 2026-03-22
  4. · Screening · HPV DNA · Repeat · Prior HPV positive
  5. · Screening result · HPV DNA · HPV detected · Adequate
  6. · Diagnostic referral · EXP-1908-T-R
  7. · Contact attempt · Unsuccessful
  8. · Diagnostic booking · Initial booking
  9. · Contact attempt · Reached
  10. · Diagnostic visit · Attended
  11. · Diagnosis · Colposcopy · Biopsy collected
  12. · Diagnosis · Histopathology · No high-grade lesion identified
  13. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-05-19
  14. · Follow-up disposition · Resolved · EXP-1908-T-R
  15. · Surveillance · HPV DNA · Surveillance · After clinical assessment
  16. · Surveillance result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-2323 · Expanded synthetic participant 2323Site B — Peri-Urban Access Programme
EXP-2324 · Expanded synthetic participant 2324Site D — Community Engagement Programme
EXP-2325 · Expanded synthetic participant 2325Site C — Rural Outreach Programme
EXP-2326 · Expanded synthetic participant 2326Site B — Peri-Urban Access Programme
EXP-2327 · Expanded synthetic participant 2327Site C — Rural Outreach Programme
EXP-2328 · Expanded synthetic participant 2328Site E — Resource-Constrained Navigation Programme
EXP-2329 · Expanded synthetic participant 2329Site A — Urban Referral Hub
EXP-2330 · Expanded synthetic participant 2330Site D — Community Engagement Programme
EXP-2331 · Expanded synthetic participant 2331Site B — Peri-Urban Access Programme
EXP-2332 · Expanded synthetic participant 2332Site D — Community Engagement Programme
EXP-2333 · Expanded synthetic participant 2333Site C — Rural Outreach Programme
EXP-2334 · Expanded synthetic participant 2334Site C — Rural Outreach Programme
EXP-2335 · Expanded synthetic participant 2335Site C — Rural Outreach Programme
EXP-2336 · Expanded synthetic participant 2336Site D — Community Engagement Programme
EXP-2337 · Expanded synthetic participant 2337Site B — Peri-Urban Access Programme
EXP-2338 · Expanded synthetic participant 2338Site D — Community Engagement Programme
EXP-2339 · Expanded synthetic participant 2339Site E — Resource-Constrained Navigation Programme
EXP-2340 · Expanded synthetic participant 2340Site B — Peri-Urban Access Programme
EXP-2341 · Expanded synthetic participant 2341Site A — Urban Referral Hub
EXP-2342 · Expanded synthetic participant 2342Site A — Urban Referral Hub
EXP-2345 · Expanded synthetic participant 2345Site C — Rural Outreach Programme
EXP-2346 · Expanded synthetic participant 2346Site A — Urban Referral Hub
EXP-2347 · Expanded synthetic participant 2347Site B — Peri-Urban Access Programme
EXP-2348 · Expanded synthetic participant 2348Site B — Peri-Urban Access Programme
EXP-2349 · Expanded synthetic participant 2349Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1970
HPV DNA
3170
Cytology
727

Navigation activity

Barrier documented
937
Contact attempt
1505
Navigation intervention
417
Diagnostic booking
1301
Diagnostic visit
1284

Documented barriers

Contact difficulty
298
Transport difficulty
311
Appointment coordination
328

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.